HuGE Literature Finder
Records
1
-
30
| Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP. Cell stress & chaperones 2022 Mar . Quinlan Philip R, Figeuredo Grazziela, Mongan Nigel, Jordan Lee B, Bray Susan E, Sreseli Roman, Ashfield Alison, Mitsch Jurgen, van den Ijssel Paul, Thompson Alastair M, Quinlan Roy |
| An investigation into the role of inherited CEACAM gene family variants and colorectal cancer risk. BMC research notes 2022 Feb 15 (1): 26. Huskey Anna L W, Merner Nancy |
| Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females. Asian Pacific journal of cancer prevention : APJCP 2022 Feb 23 (2): 641-650. Mashaly Meravt, Ghorab Doaa, Hegazy Mohamed, Abdelkhalek Mohamed, Gaballah Khaled, Elzehery Ras |
| Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer. Breast cancer research : BCR 2022 Feb 24 (1): 12. Sun Lulu, Ding Huan, Jia Yiming, Shi Mengyao, Guo Daoxia, Yang Pinni, Wang Yu, Liu Fanghua, Zhang Yonghong, Zhu Zhengb |
| Correspondence on Leptin Receptor Q223R Gene Polymorphism and Breast Cancer. Asian Pacific journal of cancer prevention : APJCP 2022 Feb 23 (2): 377. Kebayoon Amnuay, Wiwanitkit Vir |
| Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis. Breast cancer (Tokyo, Japan) 2022 Feb . Nara Miyako, Ishihara Sakiko, Kitano Atsuko, Tamura Nobuko, Aruga Tomoyuki, Kobayashi Daiki, Nakamura Seigo, Yamauchi Hide |
| DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data. Genome medicine 2022 Feb 14 (1): 21. Liu Jiaqi, Zhao Hengqiang, Zheng Yu, Dong Lin, Zhao Sen, Huang Yukuan, Huang Shengkai, Qian Tianyi, Zou Jiali, Liu Shu, Li Jun, Yan Zihui, Li Yalun, Zhang Shuo, Huang Xin, Wang Wenyan, Li Yiqun, Wang Jie, Ming Yue, Li Xiaoxin, Xing Zeyu, Qin Ling, Zhao Zhengye, Jia Ziqi, Li Jiaxin, Liu Gang, Zhang Menglu, Feng Kexin, Wu Jiang, Zhang Jianguo, Yang Yongxin, Wu Zhihong, Liu Zhihua, Ying Jianming, Wang Xin, Su Jianzhong, Wang Xiang, Wu N |
| Estimating the proportion of pathogenic variants from breast cancer case-control data: application to calibration of ACMG/AMP variant classification criteria. Human mutation 2022 Feb . James Paul A, Fortuno Cristina, Li Na, Lim Belle W X, Campbell Ian G, Spurdle Amanda |
| Estimation of associations between MMP9 gene polymorphisms and breast cancer: Evidence from a meta-analysis. The International journal of biological markers 2022 Feb 17246008221076145. Yan Cunye, Sun Chenyu, Lu Dengwei, Zhao Tianming, Ding Xiuxiu, Zamir Irma, Tang Mi, Shao Cong, Zhang F |
| Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. Biochemical genetics 2022 Feb . Allahloubi Nasr M A, Zekri Abdel-Rahman N, Ragab Mohamed, Mohanad Marwa, Ahmed Ola S, Eid Salem, Ghareeb Mohamed, Gouda Iman, Bahnassy Abeer |
| Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey. Cancer genetics 2022 Feb 262-263 118-133. Bora Elcin, Caglayan Ahmet Okay, Koc Altug, Cankaya Tufan, Ozkalayci Hande, Kocabey Mehmet, Kemer Demet, Aksoy Suleyman, Alicikus Zumre Arican, Akin Isil Basara, Durak Merih Guray, Gurel Duygu, Yavuzsen Tugba, Sevinc Ali, Somali Isil, Gorken Ilknur, Balci Pinar, Karaoglu Aziz, Saydam Serdar, Ulgenalp Ayf |
| Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer. International immunopharmacology 2022 Feb 106 108561. Cao Xi, Zhou Yidong, Mao Feng, Lin Yan, Zhou Xingtong, Sun Qia |
| Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non-Small-Cell Lung Cancer and Other Cancer Types. JCO precision oncology 2022 Feb 6 e2100325. Yin Yan, Song Lijie, Shi Dongsheng, Liu Bin, Li Xiangke, Yang Minjie, Liu Bihao, Wang Dejuan, Qin Jianw |
| Natural history and characteristics of ERBB2-mutated hormone receptor-positive advanced breast cancer: a retrospective case-control study from AACR Project GENIE. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Feb . LeNoue-Newton Michele L, Chen Sheau-Chiann, Stricker Thomas, Hyman David M, Blauvelt Natalie, Bedard Philippe L, Meric-Bernstam Funda, Punglia Rinaa S, Schrag Deborah, Lepisto Eva M, Andre Fabrice, Smyth Lillian M, Dogan Semih, Yu Celeste, Wathoo Chetna, Levy Mia, Eli Lisa D, Xu Feng, Mann Grace, Lalani Alshad S, Ye Fei, Micheel Christine M, Arnedos Moni |
| PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer. NPJ breast cancer 2022 Feb 8 (1): 24. Migliaccio Ilenia, Paoli Marta, Risi Emanuela, Biagioni Chiara, Biganzoli Laura, Benelli Matteo, Malorni Lu |
| Prevalence of type 2 diabetes mellitus in relation to arsenic exposure and metabolism in Mexican women. Environmental research 2022 Feb 210 112948. Rangel-Moreno Karla, Gamboa-Loira Brenda, López-Carrillo Lizbeth, Cebrián Mariano |
| Risk Association of Current oncology (Toronto, Ont.) 2022 Feb 29 (2): 1008-1017. Solis-Coronado Orlando, Villarreal-Vela Mónica Patricia, Rodríguez-Gutiérrez Hazyadee Frecia, González-Guerrero Juan Francisco, Cerda-Flores Ricardo M, Alcorta-Núñez Fernando, Camarillo-Cárdenas Karen Paola, Pérez-Ibave Diana Cristina, Vidal-Gutiérrez Oscar, Ramírez-Correa Genaro A, Garza-Rodríguez María Lourd |
| Risk of Second Primary Thyroid Cancer in Women with Breast Cancer. Cancers 2022 Feb 14 (4): . Cieszy?ska Monika, Klu?niak Wojciech, Woko?orczyk Dominika, Cybulski Cezary, Huzarski Tomasz, Gronwald Jacek, Falco Micha?, D?bniak Tadeusz, Jakubowska Anna, Derkacz Ró?a, Marciniak Wojciech, Lener Marcin, Woronko Karolina, Mocarz Dominika, Baszuk Piotr, Bry?kiewicz Marta, Narod Steven A, Lubi?ski J |
| The clinicopathological and prognostic significances of LATS1 expression in breast cancer. Histology and histopathology 2022 Feb 18433. Zheng Hua-Chuan, Xiang Li-Wei, Cui Zheng-Guo, Xue Hang, E Ying, Zhao Ming-Zh |
| Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland) 2022 Jan 62 52-60. Lee Soohyeon, Park Kyunghee, Kim Gun Min, Jung Kyung Hae, Kang Seok Yun, Park In Hae, Kim Jee Hyun, Ahn Hee Kyung, Park Woong-Yang, Im Seock-Ah, Park Yeon H |
| Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical Data. Cureus 2022 Jan 14 (1): e21410. Leitão Maria, Lopes Sarah, Pereira Deolinda, Medeiros Rui, Vieira Claud |
| Association of Interleukin-10 Polymorphism (rs1800896, rs1800871, and rs1800872) With Breast Cancer Risk: An Updated Meta-Analysis Based on Different Ethnic Groups. Frontiers in genetics 2022 13 829283. Li Lijun, Xiong Wei, Li Donghua, Cao Jianga |
| Energy homeostasis genes modify the association between serum concentrations of IGF-1 and IGFBP-3 and breast cancer risk. Scientific reports 2022 02 12 (1): 1837. Rodríguez-Valentín Rocío, Torres-Mejía Gabriela, Martínez-Matsushita Louis, Angeles-Llerenas Angélica, Gómez-Flores-Ramos Liliana, Wolff Roger K, Baumgartner Kathy B, Hines Lisa M, Ziv Elad, Flores-Luna Lourdes, Sánchez-Zamorano Luisa Ma, Ortiz-Panozo Eduardo, Slattery Martha |
| Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case-Control Study in Chinese Females. Frontiers in oncology 2022 12 809570. Li Liang, Meng Xingchen, Liu Liyuan, Xiang Yujuan, Wang Fei, Yu Lixiang, Zhou Fei, Zheng Chao, Zhou Wenzhong, Cui Shude, Tian Fuguo, Fan Zhimin, Geng Cuizhi, Cao Xuchen, Yang Zhenlin, Wang Xiang, Liang Hong, Wang Shu, Jiang Hongchuan, Duan Xuening, Wang Haibo, Li Guolou, Wang Qitang, Zhang Jianguo, Jin Feng, Tang Jinhai, Li Liang, Zhu Shiguang, Zuo Wenshu, Ye Chunmiao, Yin Gengshen, Ma Zhongbing, Huang Shuya, Yu Zhiga |
| The association between interleukin-1? gene polymorphisms and the risk of breast cancer: a systematic review and meta-analysis. Archives of medical science : AMS 2022 18 (1): 1-10. Wang Bei, Yuan Fenl |
| The COMT Genetic Factor Regulates Chemotherapy-Related Prospective Memory Impairment in Survivors With HER2-/+ Breast Cancer. Frontiers in oncology 2022 12 816923. Li Wen, Zhang Qianqian, Cai Yinlian, Chen Tingting, Cheng Huaido |
| Association of EGFR mutations in second primary lung cancer and HER2 expression in breast cancer survivors. Translational cancer research 2021 Dec 10 (12): 5204-5211. Jang Yoon Jung, Kim Seo Yun, Jung Hong Kyu, Kim Hye-Ryoun, Kim Cheol Hyeon, Lee Hyo-Rak, Kang Hye Jin, Yang Sung Hyun, Seol Hyesil, Na Im |
| Risk Factors of Synchronous Breast and Thyroid Cancer: a Controlled Multicenter Study and Review of the Literature. Materia socio-medica 2021 Dec 33 (4): 298-303. Zervoudis Stefanos, Iatrakis Georgios, Markja Anisa, Tsatsaris Georgios, Bothou Anastasia, von Tempelhoff Georg Fg, Balafouta Mirsini, Tsikouras Pa |
| The Interaction of NTN4 and miR-17-92 Polymorphisms on Breast Cancer Susceptibility in a Chinese Population. Clinical breast cancer 2021 Dec . Wang Yi-Shan, Guo Rong, Yang De-Chun, Xu Yi, Hui Ying-Xiang, Li Dan-Dan, Tang Shi-Cong, Tang Yi-Y |
| The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer. Discover. Oncology 2021 Aug 12 (1): 26. Korzets Yasmin, Yariv Orly, Mutai Raz, Moore Assaf, Shochat Tzippy, Yerushalmi Rinat, Goldvaser Had |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 11, 2022
- Content source: